Quality Share

How Do EGFR Point Mutations Drive Aberrant Signaling?

📅 30 December.2025

Read More →

From Suzetrigine's Approval to Ion Channel Drug Discovery: Why NaV-Overexpressing Stable Cell Lines Matter

📅 28 October.2026

Read More →

NRAS Mutations in Cancer: Gene Function, Oncogenic Signaling, and Clinically Relevant Variants

📅 16 June.2026

Read More →

G6PD Deficiency and Oxidative Stress: Gene Function, Disease Mechanisms, and Clinically Relevant Variants

📅 9 June.2026

Read More →

How Lipoprotein Particles Shape Lipid Metabolism and Disease: From Cellular Response Mechanisms to CRISPR KO Models

📅 4 June.2026

Read More →

Response to Lipoprotein Particle Pathway KO Cell Lines

📅 21 May.2026

Read More →

KRAS Mutant Cell Lines for Precision Oncology: From Allele-Specific Signaling to Targeted Therapy Resistance

📅 19 May.2026

Read More →

HAP1 Gene-Edited Cell Models: Leveraging Haploid Advantages for Precision Disease Modeling

📅 12 May.2026

Read More →

Mitophagy Mechanisms in Disease: PINK1/Parkin and BNIP3/NIX Pathways

📅 9 May.2026

Read More →

SLC Transporter Knockout Cells: From Metabolic Regulation to Drug Target Discovery

📅 24 April.2026

Read More →

VEGF Signaling Pathway Knockout Cell Lines for Angiogenesis & Disease Research

📅 24 March.2026

Read More →

Common Transfection Methods for Gene Knockout and Their Comparison

📅 5 March.2026

Read More →

CRISPR Library Screening Advanced Guide: Seven Key Experimental Points

📅 27 February.2026

Read More →

How Does the CRISPR System Distinguish Self from Foreign DNA?

📅 26 February.2026

Read More →

TP53 Point Mutation, from molecular mechanisms to therapeutic strategies

📅 27 February.2026

Read More →